- Home
- MARPS vs HKPD Comparison
MARPS vs HKPD Comparison
Compare MARPS & HKPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MARPS | HKPD |
|---|---|---|
| Founded | 1956 | 2016 |
| Country | United States | Hong Kong |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Other Pharmaceuticals |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.1M | 10.6M |
| IPO Year | N/A | 2025 |
Fundamental Metrics
Financial Performance| Metric | MARPS | HKPD |
|---|---|---|
| Price | $4.22 | $0.80 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 22.8K | ★ 48.4K |
| Earning Date | 02-13-2026 | 08-14-2025 |
| Dividend Yield | ★ 8.66% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.31 | N/A |
| Revenue | $965,040.00 | ★ $20,313,818.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $13.26 | ★ N/A |
| Revenue Growth | N/A | ★ 21.72 |
| 52 Week Low | $3.34 | $0.68 |
| 52 Week High | $7.90 | $3.79 |
Technical Indicators
Market Signals| Indicator | MARPS | HKPD |
|---|---|---|
| Relative Strength Index (RSI) | 43.90 | 45.90 |
| Support Level | $4.11 | $0.70 |
| Resistance Level | $4.44 | $0.84 |
| Average True Range (ATR) | 0.28 | 0.05 |
| MACD | -0.02 | 0.03 |
| Stochastic Oscillator | 5.18 | 86.89 |
Price Performance
Historical ComparisonAbout MARPS Marine Petroleum Trust Units of Beneficial Interest
Marine Petroleum Trust is a U.S based royalty trust. It provides administration and liquidation of rights to payments from oil and natural gas leases in the Gulf of Mexico. The Trust's subsidiary holds title to interests in properties which are situated offshore of Louisiana. The revenues of the trust are derived from the oil and natural gas production activities of third parties.
About HKPD Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares
Hong Kong Pharma Digital Technology Holdings Ltd operates in two main categories: (i) OTC pharmaceutical cross-border e-commerce supply chain services, conducted through its Hong Kong subsidiary, Joint Cross Border, which it refers to as the Supply Chain Services division, and (ii) OTC pharmaceutical cross-border procurement and distribution, conducted through its Hong Kong subsidiary, V-Alliance, which it referred to as the Procurement and Distribution division. Based in Hong Kong, Joint Cross Border has established itself as a provider of third-party supply chain services in Mainland China's OTC pharmaceutical cross-border e-commerce market.